|
|
|
|
|
|
Partner Identification: A client with a product entering Phase II sought our assistance in identifying and qualifying a small number of companies
to approach for licensing discussions. Using secondary information and conversations with target companies we were able develop a short list of targets and a
suggested approach to each company.
In-licensing Opportunity Identification: Health Advances was engaged by a large biotech company to help identify in-licensing opportunities in the
pain control field. After working with the client to develop a set of criteria and define the field, we prepared a comprehensive screen of potential opportunities
in the US and Europe. The Health Advances team spent considerable time with management reviewing the opportunities and finalizing a target list for the company's
business development team to pursue.
Out-licensing BD Support: Alongside a one-person BD function with multiple products to out-license, Health Advances worked with our client to develop
a comprehensive out-licensing package for a Phase II product. We prepared the valuation model, developed confidential and non-confidential materials, developed a
prioritized list of companies, and supported the BD person throughout the negotiations.
Identifying and Evaluating In-Licensing Candidates: A client that had completed its public offering sought our assistance in identifying and assessing
potential in-licensing candidates. Recognizing the impatience of public investors, the company sought specific products that it could pursue to supplement the existing
pipeline of early-stage, novel chemotherapeutic agents. Health Advances worked closely with the client to develop a list of key criteria, which our team then used to
identify, screen and prioritize potential in-licensing candidates for the client.
|
|
 |
|
|
|
|
